{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:22:20Z","timestamp":1780057340017,"version":"3.54.0"},"reference-count":50,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG056479"],"award-info":[{"award-number":["R01AG056479"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["agsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Benzodiazepines (BZD) and nonbenzodiazepine receptor agonist hypnotics (Z\u2010drugs) strongly increase the risk for hip fractures and should be avoided among older adults with a fall or fracture history. We assessed BZD and Z\u2010drugs refill patterns after discharge for hip fracture among older US adults and explored factors associated with refilling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of US Medicare fee\u2010for\u2010service beneficiaries (20% random sample) aged \u2265\u200966\u2009years, hospitalized for hip fracture, and discharged home or to a skilled nursing facility. Eligible patients had \u2265\u2009365\u2009days of Medicare Parts A, B, and D coverage and filled a BZD (2013\u20132019) or Z\u2010drug (2008\u20132019) \u2264\u200990\u2009days before hospitalization. We estimated cumulative incidences of refilling the same\/increased dose (continuation) and reduced dose (reduction) and their corresponding 95% confidence intervals (CI) within 180\u2009days after discharge, stratified by drug class. We examined demographic factors, comorbidities, and geriatric conditions associated with continuation versus deprescribing (reduction or no refill).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 21,123 eligible patients [11,465 (54%) on short\/intermediate\u2010acting BZD, 3473 (16%) on long\u2010acting BZD, and 6185 (29%) on Z\u2010drugs at baseline]. The median age was 82\u2009years; 81% were female and 94% were non\u2010Hispanic White. The continuation within 180\u2009days post discharge was 54.9% (95% CI: 54.0%, 55.8%) for short\/intermediate\u2010acting BZD, 58.4% (56.7%, 60.1%) for long\u2010acting BZD, and 56.0% (54.8%, 57.1%) for Z\u2010drugs; 7.2%\u201316.3% refilled with dose reductions. Younger patients or those with anxiety were at higher risk of continuation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A large proportion of US older adults on BZD or Z\u2010drugs before hospitalization for a hip fracture continued the drugs within 180\u2009days post hospital discharge. This highlights the need for comprehensive medication review and deprescribing intervention during transitions of care in this high\u2010risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jgs.70031","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T08:30:46Z","timestamp":1756456246000},"page":"3095-3104","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Patterns of Benzodiazepines and Hypnotic Drugs Dispensing After Hip Fracture Among Older\n                    <scp>US<\/scp>\n                    Adults Previously on the Drugs"],"prefix":"10.1111","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6734-0865","authenticated-orcid":false,"given":"Meng","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Epidemiology Gillings School of Global Public Health, University of North Carolina  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0974-8539","authenticated-orcid":false,"given":"Emilie D.","family":"Duchesneau","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Prevention Wake Forest University School of Medicine  Winston\u2010Salem North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse M.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Gillings School of Global Public Health, University of North Carolina  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qoua L.","family":"Her","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Gillings School of Global Public Health, University of North Carolina  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Pate","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Gillings School of Global Public Health, University of North Carolina  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keturah R.","family":"Faurot","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation School of Medicine, University of North Carolina  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7290-6838","authenticated-orcid":false,"given":"Dae Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Marcus Institute for Aging Research Hebrew SeniorLife, Harvard Medical School  Roslindale Massachusetts USA"},{"name":"Division of Gerontology Department of Medicine, Beth Israel Deaconess Medical Center  Brookline Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9204-7177","authenticated-orcid":false,"given":"Til","family":"St\u00fcrmer","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Gillings School of Global Public Health, University of North Carolina  Chapel Hill North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010021\u201099685\u2010z"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198\u2010017\u20104153\u20106"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4821"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glp003"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23373"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174730"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2019.11.003"},{"key":"e_1_2_10_9_1","volume-title":"Benzodiazepines","author":"Bounds C. G.","year":"2024"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41999\u2010023\u201000777\u2010y"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18372"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.4814"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14307"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266\u2010023\u201001066\u2010w"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.9713"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000355327"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41999\u2010022\u201000731\u20104"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102507"},{"issue":"5","key":"e_1_2_10_19_1","first-page":"339","article-title":"Deprescribing Benzodiazepine Receptor Agonists: Evidence\u2010Based Clinical Practice Guideline","volume":"64","author":"Pottie K.","year":"2018","journal-title":"Canadian Family Physician"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph181910222"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2023.09.021"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2018.08.012"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5812"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105793"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.17508"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.14759"},{"key":"e_1_2_10_27_1","unstructured":"\u201cCJR ICD\u20109 and ICD\u201010 Hip Fracture Diagnosis Codes|Guidance Portal \u201daccessed October 9 2024 https:\/\/www.hhs.gov\/guidance\/document\/cjr\u2010icd\u20109\u2010and\u2010icd\u201010\u2010hip\u2010fracture\u2010diagnosis\u2010codes."},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198\u2010017\u20104008\u20101"},{"key":"e_1_2_10_29_1","unstructured":"Centers for Medicare & Medicaid Services \u201cTransition to Part D Coverage of Benzodiazepines and Barbiturates Beginning in 2013 \u201daccessed April 22 2025 https:\/\/www.cms.gov\/Medicare\/Prescription\u2010Drug\u2010Coverage\/PrescriptionDrugCovContra\/Downloads\/BenzoandBarbituratesin2013.pdf."},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2022.28.1.58"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.07.024"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13807"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3719"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwad151"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.10.004"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000824"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102021\u2010052057"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2329"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2018.10.017"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2023.22205"},{"issue":"3","key":"e_1_2_10_41_1","first-page":"141","article-title":"An Empirical Transition Matrix for Non\u2010Homogeneous Markov Chains Based on Censored Observations","volume":"5","author":"Aalen O. O.","year":"1978","journal-title":"Scandinavian Journal of Statistics"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2019.011"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.09.017"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40471\u2010016\u20100089\u20101"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2021.07.004"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr213"},{"key":"e_1_2_10_47_1","unstructured":"M.Freed J. F.Biniek A.Damico andT. N.Published \u201cMedicare Advantage in 2024: Enrollment Update and Key Trends \u201dKFF August 8 2024 accessed February 14 2025 https:\/\/www.kff.org\/medicare\/issue\u2010brief\/medicare\u2010advantage\u2010in\u20102024\u2010enrollment\u2010update\u2010and\u2010key\u2010trends\/."},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.31067"},{"key":"e_1_2_10_49_1","unstructured":"FDA \u201cResearch C for DE and. FDA Requiring Boxed Warning Updated to Improve Safe Use of Benzodiazepine Drug Class \u201dPublished online August 1 2024 accessed February 13 2025 https:\/\/www.fda.gov\/drugs\/drug\u2010safety\u2010and\u2010availability\/fda\u2010requiring\u2010boxed\u2010warning\u2010updated\u2010improve\u2010safe\u2010use\u2010benzodiazepine\u2010drug\u2010class."},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm\u20102015\u2010000864"},{"key":"e_1_2_10_51_1","unstructured":"Deprescribing.org\u2014Optimizing Medication Use \u201cDeprescribing.org \u201daccessed April 9 2025 https:\/\/deprescribing.org\/."}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.70031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T11:32:35Z","timestamp":1764415955000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/jgs.70031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1111\/jgs.70031"],"URL":"https:\/\/doi.org\/10.1111\/jgs.70031","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"2025-03-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}